# Flexion Therapeutics Inc

Flexion Therapeutics Inc is a company headquartered in Burlington, MA, United States.

## Company overview

- **Legal name:** Flexion Therapeutics Inc
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Burlington, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001419600

## About

Flexion Therapeutics Inc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001419600, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2021-03-10, it reported annual revenue of USD 85,552,000; net income of USD -113,706,000; total assets of USD 251,926,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2020 (period ended 2020-12-31)

- **Revenue:** $85.6M (USD 85,552,000)
- **Net income:** -$113.7M (USD -113,706,000)
- **Total assets:** $251.9M (USD 251,926,000)
- **Cash and equivalents:** $107.7M (USD 107,704,000)
- **Operating cash flow:** -$70.6M (USD -70,561,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $73.0M (USD 72,957,000)
- **Net income:** -$149.8M (USD -149,773,000)
- **Total assets:** $217.6M (USD 217,560,000)
- **Cash and equivalents:** $82.3M (USD 82,253,000)
- **Operating cash flow:** -$148.8M (USD -148,758,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $22.5M (USD 22,524,000)
- **Net income:** -$169.7M (USD -169,659,000)
- **Total assets:** $295.8M (USD 295,752,000)
- **Cash and equivalents:** $87.2M (USD 87,229,000)
- **Operating cash flow:** -$160.4M (USD -160,419,000)

### FY2017 (period ended 2017-12-31)

- **Net income:** -$137.5M (USD -137,481,000)
- **Total assets:** $441.3M (USD 441,317,000)
- **Cash and equivalents:** $127.8M (USD 127,789,000)

## Recent SEC filings

- Form SC 13G — filed 2021-11-24 — SC 13G/A
- Form 8-K — filed 2021-11-19 — period 2021-11-19 — FORM 8-K
- Form 10-Q — filed 2021-11-12 — period 2021-09-30 — 10-Q
- Form 8-K — filed 2021-10-12 — period 2021-10-11 — FORM 8-K
- Form 10-Q — filed 2021-08-04 — period 2021-06-30 — 10-Q
- Form 8-K — filed 2021-08-04 — period 2021-08-04 — 8-K
- Form 8-K — filed 2021-07-12 — period 2021-07-09 — 8-K
- Form 8-K — filed 2021-06-25 — period 2021-06-24 — 8-K
- Form 10-Q — filed 2021-05-12 — period 2021-03-31 — 10-Q
- Form 8-K — filed 2021-05-12 — period 2021-05-07 — 8-K
- Form 8-K — filed 2021-05-11 — period 2021-05-11 — 8-K
- Form DEF 14A — filed 2021-04-29 — period 2021-06-24 — DEF 14A

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/flexion-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology